FaDu Cells

FaDu is a human cell line derived from a squamous cell carcinoma of the hypopharynx. Established from a tumor in an adult patient, FaDu cells are frequently used in medical research focusing on cancer biology, particularly in studies related to head and neck cancers. These cells exhibit epithelial morphology and are adherent in culture conditions. FaDu is known for its robust growth and is often employed in assays to understand cancer cell proliferation, response to therapeutic agents, and gene expression related to cancer progression and metastasis. In scientific research, FaDu cells have been instrumental in examining the efficacy of radiotherapy and chemotherapy treatments, providing insights into cellular responses to DNA damage and repair mechanisms. The cell line has also been utilized in studies exploring molecular pathways involved in cancer, such as the EGFR signaling pathway, which is often altered in head and neck cancers. The versatility and relevance of FaDu cells make them a valuable model for oncology research, contributing to the development of targeted therapies and understanding cancer cell biology at a molecular level. Head-Neck cancer cell lines, Pharynx, Hypopharyngeal squamous cell carcinoma, Growth Conditions: Adherent, Biosafety level: BSL 1